Literature DB >> 8009973

Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results.

H Gjønnaess1.   

Abstract

During the years 1979-91 252 women with polycystic ovarian syndrome (PCOS) have been treated with ovarian electrocautery through the laparoscope in Aker University Hospital. Ovulation was obtained in 92% of the total series, and pregnancy in 84% of the women with PCOS as the sole cause of their infertility. Additional treatment with clomiphene citrate to the non-responders increased the pregnancy rate to 89%. The response to ovarian electrocautery was influenced by body weight, with an ovulation rae of 96-97% in the slim and moderately obese women decreasing to 70% in the really obese ones. When ovulation was established, the pregnancy rate per se was independent of body weight-when ovulation was established, the pregnancy rates of slim and overweight women with PCOS being 92% and 95%, respectively. In the responders (who ovulated following ovarian electrocautery), the annual rate of cessation of ovulation was 3-4% only. Even after a period of contraceptive use following the ovarian electrocautery, ovulation was resumed and pregnancy obtained within a few months. Therefore, ovarian electrocautery is proposed as the primary treatment in women with PCOS undergoing laparoscopy for any reason, infertility being a present, future or hypothetical problem only. When, on the other hand, infertility is not an issue, PCOS per se constitutes no reason to perform laparoscopy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009973     DOI: 10.3109/00016349409006253

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

1.  Surgical Approach for Polycystic Ovarian Syndrome in Management of Infertility.

Authors:  S K Rath; R K Sharma; B S Duggal
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Perioperative androstenedione kinetics in women undergoing laparoscopic ovarian drilling: a prospective study.

Authors:  Johannes Ott; Klaus Mayerhofer; Kazem Nouri; Katharina Walch; Rudolf Seemann; Christine Kurz
Journal:  Endocrine       Date:  2014-04-17       Impact factor: 3.633

Review 3.  Polycystic ovary syndrome: current status and future perspective.

Authors:  Erin K Barthelmess; Rajesh K Naz
Journal:  Front Biosci (Elite Ed)       Date:  2014-01-01

4.  Treatment options for polycystic ovary syndrome.

Authors:  Ahmed Badawy; Abubaker Elnashar
Journal:  Int J Womens Health       Date:  2011-02-08

Review 5.  Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome.

Authors:  Subarna Mitra; Prasanta Kumar Nayak; Sarita Agrawal
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

6.  The local effects of ovarian diathermy in an ovine model of polycystic ovary syndrome.

Authors:  Fiona Connolly; Michael T Rae; Mairead Butler; Alexander L Klibanov; Vassilis Sboros; Alan S McNeilly; W Colin Duncan
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

7.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

8.  Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study.

Authors:  Johannes Ott; Stefan Wirth; Kazem Nouri; Christine Kurz; Klaus Mayerhofer; Johannes C Huber; Clemens B Tempfer
Journal:  Reprod Biol Endocrinol       Date:  2009-12-30       Impact factor: 5.211

Review 9.  The management of infertility associated with polycystic ovary syndrome.

Authors:  Roy Homburg
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

Review 10.  Epidemiology, diagnosis, and management of polycystic ovary syndrome.

Authors:  Susan M Sirmans; Kristen A Pate
Journal:  Clin Epidemiol       Date:  2013-12-18       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.